NICE issues draft guidance on avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapy
In DRAFT guidance, NICE does not recommend avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer that has not progressed after platinum-based chemotherapy in adults.
Source:
National Institute for Health and Care Excellence